Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pan-Chyr Yang

Showing results (341-350 of 495) with videos related to

Pageof 50
Sort By:
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 4, 2011
Invasive infections of Aggregatibacter (Actinobacillus) actinomycetemcomitansCheng-Yi Wang, Hui-Chih Wang, Jang-Ming Li, et al.
Journal of Proteome Research|September 7, 2010
An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasionYi-Ting Wang, Chia-Feng Tsai, Tzu-Chan Hong, et al.
Scientific Reports|September 25, 2015
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer ProgressionAng Yuan, Yi-Jing Hsiao, Hsuan-Yu Chen, et al.
Bioorganic & Medicinal Chemistry|February 8, 2011
Antitumor agents 283. Further elaboration of desmosdumotin C analogs as potent antitumor agents: activation of spindle assembly checkpoint as possible mode of actionKyoko Nakagawa-Goto, Pei-Chi Wu, Kenneth F Bastow, et al.
American Journal of Respiratory and Critical Care Medicine|June 28, 2008
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancerJenn-Yu Wu, Chong-Jen Yu, Chih-Hsin Yang, et al.
The Journal of Pathology|August 19, 2014
Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancerWei-Yu Liao, Chao-Chi Ho, Hsin-Han Hou, et al.
Cancer Medicine|April 4, 2019
Tumor mutation burden and recurrent tumors in hereditary lung cancerYi-Chiung Hsu, Ya-Hsuan Chang, Gee-Chen Chang, et al.
Scientific Reports|April 23, 2021
Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza virusesSui-Yuan Chang, Kuo-Yen Huang, Tai-Ling Chao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 31, 2010
Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking womenTzu-Pin Lu, Mong-Hsun Tsai, Jang-Ming Lee, et al.
Radiology|August 2, 2005
Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CTYeun-Chung Chang, Chong-Jen Yu, Shan-Chwen Chang, et al.
Pageof 50

Showing results (341-350 of 495) with videos related to

Sort By:
Pageof 50
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 4, 2011
Invasive infections of Aggregatibacter (Actinobacillus) actinomycetemcomitansCheng-Yi Wang, Hui-Chih Wang, Jang-Ming Li, et al.
Journal of Proteome Research|September 7, 2010
An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasionYi-Ting Wang, Chia-Feng Tsai, Tzu-Chan Hong, et al.
Scientific Reports|September 25, 2015
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer ProgressionAng Yuan, Yi-Jing Hsiao, Hsuan-Yu Chen, et al.
Bioorganic & Medicinal Chemistry|February 8, 2011
Antitumor agents 283. Further elaboration of desmosdumotin C analogs as potent antitumor agents: activation of spindle assembly checkpoint as possible mode of actionKyoko Nakagawa-Goto, Pei-Chi Wu, Kenneth F Bastow, et al.
American Journal of Respiratory and Critical Care Medicine|June 28, 2008
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancerJenn-Yu Wu, Chong-Jen Yu, Chih-Hsin Yang, et al.
The Journal of Pathology|August 19, 2014
Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancerWei-Yu Liao, Chao-Chi Ho, Hsin-Han Hou, et al.
Cancer Medicine|April 4, 2019
Tumor mutation burden and recurrent tumors in hereditary lung cancerYi-Chiung Hsu, Ya-Hsuan Chang, Gee-Chen Chang, et al.
Scientific Reports|April 23, 2021
Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza virusesSui-Yuan Chang, Kuo-Yen Huang, Tai-Ling Chao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 31, 2010
Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking womenTzu-Pin Lu, Mong-Hsun Tsai, Jang-Ming Lee, et al.
Radiology|August 2, 2005
Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CTYeun-Chung Chang, Chong-Jen Yu, Shan-Chwen Chang, et al.
Pageof 50